Skip to main content
Menu
ABOUT US
COMPANY OVERVIEW
EXECUTIVE TEAM
SENIOR LEADERSHIP TEAM
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARDS
PARTNERSHIPS
PIPELINE
OUR PIPELINE
Pemvidutide
HepTcell™
INVESTORS
OVERVIEW
PRESS RELEASES
PRESS RELEASES
PHARMATHENE, INC. HISTORICAL PRESS RELEASES
IN THE NEWS
EVENTS AND PRESENTATIONS
STOCK INFORMATION
STOCK QUOTE & CHART
HISTORICAL PRICE LOOKUP
INVESTMENT CALCULATOR
ANALYST COVERAGE
GOVERNANCE
DOCUMENTS & CHARTERS
MANAGEMENT TEAM
BOARD OF DIRECTORS
COMMITTEE COMPOSITION
FINANCIALS
SEC FILINGS
ANNUAL REPORTS
INVESTOR RESOURCES
IR CONTACT
EMAIL ALERTS
CLINICAL TRIALS
JOIN TRIAL
CAREERS
CONTACT US
PIPELINE
Obesity & liver diseases
Close Menu
ABOUT US
COMPANY OVERVIEW
EXECUTIVE TEAM
SENIOR LEADERSHIP TEAM
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARDS
PARTNERSHIPS
PIPELINE
OUR PIPELINE
Pemvidutide
HepTcell™
INVESTORS
OVERVIEW
PRESS RELEASES
PRESS RELEASES
PHARMATHENE, INC. HISTORICAL PRESS RELEASES
IN THE NEWS
EVENTS AND PRESENTATIONS
STOCK INFORMATION
STOCK QUOTE & CHART
HISTORICAL PRICE LOOKUP
INVESTMENT CALCULATOR
ANALYST COVERAGE
GOVERNANCE
DOCUMENTS & CHARTERS
MANAGEMENT TEAM
BOARD OF DIRECTORS
COMMITTEE COMPOSITION
FINANCIALS
SEC FILINGS
ANNUAL REPORTS
INVESTOR RESOURCES
IR CONTACT
EMAIL ALERTS
CLINICAL TRIALS
JOIN TRIAL
CAREERS
CONTACT US
